Key facts
- Notable investors include Biosciences Research and Commercialization Center.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CareLens
- ·The full record, as it builds
Funding rounds
No funding rounds for CareLens are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CareLens
Developer of an AI-based observational analytics software designed to improve workflow efficiency and capacity planning for surgery centers. The company uses AI-based observational analytics deployed on-premise to capture and process procedural events and workflow activities in real time, providing latency-sensitive insights into room status, case progress, turnover intervals, and schedule adherence, maintaining data privacy and regulatory compliance, and integrating with existing operational systems, enabling surgery centers to improve workflow automation and align capacity with demand.
- Sector
- Healthcare
- HQ
- Kalamazoo, MI, United States
- Founded
- 2024
- Website
- carelens.ai/
- Ownership
- Privately Held (backing)
CareLens doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CareLens shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CareLens in its N-PORT filings yet. We sweep new filings monthly.